GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Merck & Co Inc (NYSE:MRK) » Definitions » 3-Year Dividend Growth Rate

Merck (MRK) 3-Year Dividend Growth Rate

: 6.10% (As of Dec. 2023)
View and export this data going back to 1949. Start your Free Trial

Merck's Dividends per Share for the three months ended in Dec. 2023 was $0.77.

The historical rank and industry rank for Merck's 3-Year Dividend Growth Rate or its related term are showing as below:

MRK' s 3-Year Dividend Growth Rate Range Over the Past 10 Years
Min: 0.4   Med: 8.2   Max: 109.5
Current: 6.1

During the past 13 years, the highest 3-Year average Dividends Per Share Growth Rate of Merck was 109.50% per year. The lowest was 0.40% per year. And the median was 8.20% per year.

MRK's 3-Year Dividend Growth Rate is ranked worse than
57.94% of 321 companies
in the Drug Manufacturers industry
Industry Median: 8.7 vs MRK: 6.10

During the past 12 months, Merck's average Dividends Per Share Growth Rate was 5.70% per year. During the past 3 years, the average Dividends Per Share Growth Rate was 6.10% per year. During the past 5 years, the average Dividends Per Share Growth Rate was 8.00% per year. During the past 10 years, the average Dividends Per Share Growth Rate was 6.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.

Merck's Dividend Payout Ratio for the three months ended in Dec. 2023 was 25.67. As of today, Merck's Dividend Yield % is 2.41%.

Warning Sign:

If a company's dividend payout ratio is too high, its dividend may not be sustainable. The dividend payout ratio of Merck & Co Inc is 1.97, which seems too high.

Warning Sign:

Merck & Co Inc stock dividend yield is close to 10-year low.

For more information regarding to dividend, please check our Dividend Page.


Competitive Comparison

For the Drug Manufacturers - General subindustry, Merck's 3-Year Dividend Growth Rate, along with its competitors' market caps and 3-Year Dividend Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Merck 3-Year Dividend Growth Rate Distribution

For the Drug Manufacturers industry and Healthcare sector, Merck's 3-Year Dividend Growth Rate distribution charts can be found below:

* The bar in red indicates where Merck's 3-Year Dividend Growth Rate falls into.



Merck 3-Year Dividend Growth Rate Calculation

This is the average annual rate that a company has been raising its dividends. The growth rate is calculated with expontential compound based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.


Merck  (NYSE:MRK) 3-Year Dividend Growth Rate Explanation

1. Dividend Payout Ratio measures the percentage of the company's earnings paid out as dividends.

Merck's Dividend Payout Ratio for the quarter that ended in Dec. 2023 is calculated as

Dividend Payout Ratio=Dividends per Share (Q: Dec. 2023 )/ EPS without NRI (Q: Dec. 2023 )
=0.77/ 0.03
=25.67

During the past 13 years, the highest Dividend Payout Ratio of Merck was 1.97. The lowest was 0.37. And the median was 0.50.

Warning Sign:

If a company's dividend payout ratio is too high, its dividend may not be sustainable. The dividend payout ratio of Merck & Co Inc is 1.97, which seems too high.

2. Dividend Yield % measures how much a company pays out in dividends each year relative to its share price.

Merck Recent Full-Year* Dividend History

Amount Ex-date Record Date Pay Date Type Frequency Forex Rate
USD 0.7702024-03-142024-03-152024-04-05Cash DividendquarterlyUSD:USD 1.000000
USD 0.7702023-12-142023-12-152024-01-08Cash DividendquarterlyUSD:USD 1.000000
USD 0.7302023-09-142023-09-152023-10-06Cash DividendquarterlyUSD:USD 1.000000
USD 0.7302023-06-142023-06-152023-07-10Cash DividendquarterlyUSD:USD 1.000000

* GuruFocus has an internal rule that if the most recent dividend payment frequency is at least 4 times a year, then the full year will be calculated according to the frequency of payment or the one-year time frame, whichever is stricter.
* GuruFocus converts dividend currency to local traded share price currency in order to calculate dividend yield. Please refer to the last column "Forex Rate" in the above table.

Merck's Dividend Yield (%) for Today is calculated as

Dividend Yield %=Most Recent Full Year Dividend/Current Share Price
=3/125.23
=2.40 %

Current Share Price is $125.23.
Merck's Dividends per Share for the trailing twelve months (TTM) ended in Today is $3.

During the past 13 years, the highest Dividend Yield of Merck was 3.99%. The lowest was 2.24%. And the median was 3.13%.

Warning Sign:

Merck & Co Inc stock dividend yield is close to 10-year low.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Merck 3-Year Dividend Growth Rate Related Terms>


Merck (MRK) Business Description

Address
126 East Lincoln Avenue, Rahway, NJ, USA, 07065
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform is growing as a major contributor to overall sales. The company also has a substantial vaccine business, with treatments to prevent pediatric diseases as well as human papillomavirus, or HPV. Additionally, Merck sells animal health-related drugs. From a geographical perspective, just under half of the company's sales are generated in the United States.
Executives
Johannes Jacobus Oosthuizen officer: SVP, U.S. Market 2000 GALLOPING HILL RD, KENILWORTH NJ 07033
Richard R. Deluca officer: EVP&Pres, Merck Animal Heallth 2000 GALLOPING HILL ROAD, KENILWORTH NJ 07033
Steven Mizell officer: EVP,Human Resources 2000 GALLOPING HILL ROAD, KENILWORTH NJ 07033
Joseph Romanelli officer: President, Human Health Int?l 126 EAST LINCOLN AVENUE, RAHWAY NJ 07065
Rita A Karachun officer: Sr. VP Fince-Global Controller 2000 GALLOPING HILL ROAD, KENILWORTH NJ 07033
Jennifer Zachary officer: EVP, General Counsel 2000 GALLOPING HILL ROAD, KENILWORTH NJ 07033
David Michael Williams officer: EVP,Chief Info&Digital Officer MERCK & CO., INC., 2000 GALLOPING HILL ROAD, KENILWORTH NJ 07033
Robert M Davis officer: Evp, Global Svcs & CFO 2000 GALLOPING HILL ROAD, KENILWORTH NJ 07033
Sanat Chattopadhyay officer: Exe V-P & Pres. MMD 2000 GALLOPING HILL ROAD, KENILWORTH NJ 07033
Kenneth C Frazier officer: Chairman, President & CEO 2000 GALLOPING HILL ROAD, KENILWORTH NJ 07033
Chirfi Guindo officer: Chief Marketing Officer C/O BIOGEN INC., 225 BINNEY ST., CAMBRIDGE MA 02142
Baker Douglas M Jr director 370 WBASHA ST NORTH, ST PAUL MN 55102
Arpa Garay officer: SVP Human Health Global Mktg. 2000 GALLOPING HILL RD, KENILWORTH NJ 07033
Caroline Litchfield officer: EVP & CFO 2000 GALLOPING HILL RD, KENILWORTH NJ 07033
Julie L. Gerberding officer: EVP Strat Comm, GI Pub Policy 2000 GALLOPING HILL ROAD, KENILWORTH NJ 07033

Merck (MRK) Headlines

From GuruFocus

Q1 2023 Merck & Co Inc Earnings Call Transcript

By GuruFocus Research 01-23-2024

Q2 2023 Merck & Co Inc Earnings Call Transcript

By GuruFocus Research 01-23-2024

Merck & Co Inc To Host ESMO Call (Virtual) Transcript

By GuruFocus Research 01-23-2024

Merck Announces Second-Quarter 2024 Dividend

By Business Wire 01-23-2024

Merck & Co Inc at UBS BioPharma Conference Transcript

By GuruFocus Research 01-23-2024

Q3 2022 Merck & Co Inc Earnings Call Transcript

By GuruFocus Research 01-23-2024